Impact of liver test abnormalities and chronic liver disease on the clinical outcomes of patients hospitalized with COVID-19
Keywords:
acute liver injury, chronic liver disease, COVID-19, SARS-Cov-2Abstract
INTRODUCTION: The severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) or novel corona virus disease (COVID-19) pandemic is sweeping the globe. Latest information on the outbreak of the corona virus epidemic in 2019, which was caused by the extreme acute respiratory syndrome corona virus 2 strains, has begun to shed light on the disease's effects on the liver. However, no studies have systematically to date, there have been no impaired liver tests in COVID-19 patients. In patients with irregular liver test results, we looked at the clinical features of COVID-19. The goal of this research was to explain the clinical outcomes of COVID-19 in patients with irregular liver tests and CLD. AIM: We performed an observational study to see how irregular liver tests and patients' clinical outcomes were influenced by chronic liver disease admitted to SMHRC Nagpur. MATERIAL AND METHODS: The research included 200 people aged 25 to 65 years old who had been diagnosed with corona positive and were admitted to Shalinitai Meghe Hospital in Nagpur. They were split up into different parties. One group had chronic liver disease, and the other did not, but both groups had patients that were corona positive.
Downloads
References
WHO Director-General's opening remarks at the media briefing on COVID-19. (2020).https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-themedia-briefing-on-covid-19-11.
Vishwa S. P, Ravi P. Effect of COVID 19 Affecting Geriatric Patients. Int J Cur Res Rev. Vol 12 Issue 17, September, 2020, 182-187.
WHO. Corona virus disease 2019 (COVID-19): situation report,73.(2020). https://apps.who.int/iris/handle/10665/331686.
Rucha R. Lohi, Nikita Dhahikar, Ranjit Ambad, Dhruba Hari Chandi. Online Teaching in the Time of Covid 19-Effectiveness and Challenges. Indian Journal of Forensic Medicine & Toxicology, October-December 2020, Vol. 14, No. 4; 6841-6844.
Wu Z, Mc Googan JM. Characteristics of and important lessons from the corona virus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020
World Health Organization. Situation report - 120; Corona virus disease 2019 (COVID-19). Available at, 2020.
Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol 2020;5(5):428–430
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel corona virus-infected pneumonia in Wuhan, China. JAMA 2020;323:1061–1069.
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. China Medical Treatment Expert Group for Covid-19. Clinical characteristics of corona virus disease 2019 in China. N Engl J Med 2020;382:1708–1720.
Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020;8(4):420–422.
Tian S, Xiong Y, Liu H, Niu H, Guo J, Liao M, et al. Pathological study of the 2019 novel corona virus disease (COVID-19) through postmortem core biopsies. Mod Pathol 2020;33(6):1007–1014.
Mantovani A, Beatrice G, Dalbeni A. Corona virus disease 2019 and prevalence of chronic liver disease: A meta-analysis. Liver Int. 2020;40(6):1316–20.
Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with corona virus disease 2019: retrospective study. BMJ 2020;368:1091
Singh S, Khan A: Clinical characteristics and outcomes of COVID-19 among patients with preexisting liver disease in United States: a multi-center research network study. Gastroenterology.2020.04.064
Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol 2020; 5: 428-430
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
